Neurological Conditions · Regenerative Medicine

Stem Cell Therapy for Multiple Sclerosis

Multiple Sclerosis doesn’t have to mean a life defined by what you can no longer do.

Over 10 years and hundreds of MS patients later, we know what this therapy can do and what it can’t. The science continues to confirm what we’ve seen clinically: stabilization, fewer relapses, less fatigue, and a quality of life that conventional treatment alone wasn’t delivering.

What is multiple sclerosis?

When the immune system turns against the nervous system

Multiple sclerosis is an autoimmune condition in which the immune system attacks myelin or the protective sheath surrounding nerve fibers in the brain and spinal cord. As myelin breaks down, electrical signals between the brain and the rest of the body are disrupted, leading to progressive loss of function.

The result is a condition that affects every patient differently. In relapsing-remitting MS (RRMS), the most common form, symptoms flare and partially recover. In progressive forms, decline is steadier and harder to reverse. Either way, without intervention, disability accumulates over time.

Standard disease-modifying drugs reduce relapse frequency and slow progression in some patients. But they don’t repair existing damage, and for a significant portion of patients they are not enough.

Compared to standard immunotherapy, stem cell and exosome treatments have been associated with disease stabilization, delayed progression, improved disability scores, reduced brain lesion volume, enhanced cognitive function, and increased life expectancy accompanied by reductions in biomarkers of disease activity in both blood and cerebrospinal fluid.

HOW CAN ALEVY'S ADVANCED THERAPY TREATMENTS HELP YOU?

Beyond symptom management. Targeting the disease itself.

Most of our MS patients arrive after years of relapses and medication changes that weren’t enough. Regenerative medicine offers a different starting point. Advanced stem cell and exosome therapies don’t just manage what’s happening. They work to interrupt the process driving your Multiple Sclerosis forward, reducing the immune activity attacking your myelin and supporting your nervous system from the inside out.

Disease stabilization

Mesenchymal Stem Cells and exosome therapy have demonstrated the ability to halt disease activity and not just slow it. Patients show stabilization in disability progression where conventional therapies have failed to hold the line. Source: Islam et al., J Clin Med 2023, Vaheb et al., 2024 Vaheb et al., 2024

Improved disability scores

Clinical trials report meaningful improvements in Expanded Disability Status Scale (EDSS) scores (the standard measure of MS disability) reflecting real functional gains in mobility, coordination, and independence. Source: Nawar et al., Sci Rep 2024

Reduced brain lesion volume

MRI findings in treated patients show reductions in brain lesion volumem an objective, measurable evidence of decreased inflammatory activity in the central nervous system following stem cell therapy. Source: Islam et al., J Clin Med 2023

Fatigue and cognitive improvement

Fatigue affects up to 80% of MS patients and is rarely addressed by disease-modifying drugs. As neuroinflammation decreases following MSC therapy, many patients report meaningful improvements in both energy levels and cognitive clarity. Source: Wu et al., Front Neurol 2024

Reduced disease biomarkers

Beyond clinical scores, treated patients show measurable reductions in blood and cerebrospinal fluid biomarkers of disease activity — biological confirmation that the underlying inflammatory process is being modulated. Source: Sheikhi et al., Front Cell Dev Biol 2025

The research

What the clinical and scientific evidence shows

Over ten years of treating MS patients has taught us something the research is now catching up to: the right protocol, matched to the right patient, changes outcomes. Relapsing-remitting forms tend to respond strongest and that pattern holds in our clinical experience as much as it does in the literature.

MSC therapy in MS: A systematic review & meta-analysis

READ STUDY

HOW IT WORKS

5 Steps to Your Advanced Therapy Treatment Plan

Schedule Your Consultation

Book a free consultation with one of our Patient Care Specialists who will provide guidance and answer your questions.

Send Your Medical Records

Our clinical team reviews your diagnosis, history, and current treatment at no cost, and with no obligation to proceed.

Receive Your Personalized Plan

A personalized protocol prepared by our physicians based on your specific case. Your referring physician can review it alongside you.

Plan Your Visit

Our patient support
team will assist you
with scheduling your
treatment and help
coordinate your visit,
making the process
stress-free.

Ongoing Care and Support

After your treatment,
we stay connected to
monitor your progress
and provide continued
guidance. Our team is
dedicated to your long-term well-being, ensuring
you get the best results
from your therapy.

Why Alevy for MS

A treatment center built for the complexity MS actually involves

MS is not a single disease. The subtype, the stage, the current medication, and the patient’s history all shape what treatment looks like. Our medical team has spent 10+ years developing the clinical depth that a condition this variable demands.

ISO-certified biotechnology laboratory

Our lab in Pereira operates under international quality standards with processes and documentation that most clinics in North America and Europe cannot match in-house.

Wharton's jelly MSC sourcing

Ethically sourced mesenchymal stem cells from umbilical cord tissue that is ISCT compliant, high potency, and with a low immune rejection profile.

High-dose protocols

Cell dosage ranges that exceed what regulatory restrictions currently permit in the US and Canada and are administered under direct clinical supervision by our medical team.

10+ years of clinical experience

Our medical team has treated complex neurological cases across more than 10 years. Providing experience that most regenerative medicine clinics at this stage of the field don't have.

FREQUENTLY ASKED QUESTIONS

Your Questions Answered

01 Does stem cell therapy work for multiple sclerosis?

The clinical evidence is no longer described as preliminary. A 2023 systematic review and meta-analysis published in the Journal of Clinical Medicine confirmed disease stabilization, improved disability scores, reduced brain lesion volume, and enhanced cognitive function in MS patients treated with MSC therapy. In head-to-head comparisons with high-efficacy disease-modifying drugs including natalizumab, stem cell therapy proved more effective and less expensive in patients with aggressive relapsing-remitting MS. Leading neurological organizations have formally recommended regenerative approaches for severe forms of the disease. It does not cure MS but the evidence supports its role as a disease-modifying approach that goes significantly beyond what symptom management alone can offer.

02 How can stem cell therapy treat multiple sclerosis?

MS is fundamentally an immune system problem where the body attacks its own myelin, disrupting the signals the brain sends to the rest of the body. Mesenchymal stem cells modulate the immune response, reducing the autoimmune activity driving myelin destruction, while also promoting repair in damaged areas of the central nervous system. Exosome therapy works alongside this by delivering anti-inflammatory signals directly to affected tissue. How this applies to your specific subtype and disease history is something our physician can walk you through directly. Request your protocol and we will schedule a consultation to answer your questions.

03 How much does stem cell treatment for multiple sclerosis cost?

Treatment cost depends on your specific protocol — the cell type, dosage, number of sessions, and the complexity of your case. MS treatment requires higher cell concentrations and a protocol designed around your specific subtype and disease stage. The most accurate way to receive pricing is to submit your medical records for review. Our clinical team will prepare a personalized protocol with full pricing. There is no commitment required to receive it.

04 Can stem cell therapy help with MS fatigue?

Fatigue is one of the most debilitating and undertreated symptoms of multiple sclerosis and one of the least addressed by conventional disease-modifying drugs. MSC therapy works by reducing the chronic neuroinflammation that drives central fatigue in MS patients. As the inflammatory load decreases and the immune environment in the central nervous system stabilizes, many patients report meaningful improvements in energy levels and cognitive clarity.

05 Where can I get stem cell therapy for MS near me?

If you are based in the United States or Canada, stem cell therapy for MS is available domestically but with significant limitations. Regulatory restrictions mean that most clinics are limited to using your own cells, which have already aged and carry the same immune dysfunction driving your MS. Dosage is also tightly regulated, often well below what clinical evidence suggests is needed for meaningful results. For patients who want access to younger, ethically sourced donor cells at therapeutic dosage levels, specialized clinics outside North America offer a meaningful alternative. Colombia has become a recognized destination for regenerative medicine combining established clinical infrastructure, internationally certified laboratories, and significantly lower treatment costs than comparable clinics in abroad. Alevy's treatment center in Pereira, Colombia is within a four to five hour flight from most major US and Canadian cities.